Paxil Tablet, Film Coated, Extended Release
Product Images NDC 60505-4379

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Paxil (NDC 60505-4379). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1

A scatter plot chart depicting fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of various interacting drugs (Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, Phenytoin 300 mg) relative to a reference. The x-axis shows fold change on a logarithmic scale from 0.1 to 10.*

FDA Label Image

Figure2

A forest plot graph showing pharmacokinetic interactions of various drugs (Cimetidine, Phenobarbital, Phenytoin, Digoxin, Diazepam) with fold change and 90% confidence intervals (CI) in Cmax and AUC relative to a reference. The x-axis represents the change relative to reference from 0 to 2.*

FDA Label Image

Figure3

A forest plot chart depicting pharmacokinetic parameters (Cmax, AUC, Cmin) fold changes with 90% confidence intervals for PAXIL CR 12.5 mg, 25 mg, and 37.5 mg related to populations with renal impairment (mild, moderate, severe), hepatic impairment, age over 65 with varying doses, and gender (males). The x-axis represents change relative to reference on a logarithmic scale.*

FDA Label Image

Paxilcr12.5mg30counttabletlabel Gsk

Label of PAXIL CR 12.5 mg controlled-release tablets containing paroxetine hydrochloride. The label states a quantity of 30 tablets, lists Apotex Corp as the distributor, and GlaxoSmithKline as the manufacturer. It includes a barcode, a federal law warning for dispensing with the Medication Guide, storage instructions, and the NDC 60505-3668-3.*

FDA Label Image

Paxilcr12.5mg30counttabletlabel

Label for PAXIL CR extended-release tablets 12.5 mg, each containing paroxetine hydrochloride equivalent to 12.5 mg paroxetine. The label states storage conditions, dosage reference, safety closure warning, and includes manufacturer Apotex Corp details, a barcode, and the package count of 30 tablets.*

FDA Label Image

Paxilcr25mg30counttabletlabel Gsk

Label for PAXIL CR 25 mg controlled-release tablets containing paroxetine hydrochloride. The label includes NDC 60505-3669-3 and indicates a package size of 30 tablets. It also notes Apotex Corp. as the distributor and GlaxoSmithKline as the manufacturer. The label includes storage instructions, dispensing warnings, and manufacturing location in Canada.*

FDA Label Image

Paxilcr25mg30counttabletlabel

Label for PAXIL CR 25 mg extended-release tablets by Apotex Corp. The label includes dosage information, storage instructions to keep at or below 25°C, and a note advising to see accompanying prescribing information. The label specifies the product contains paroxetine hydrochloride equivalent to 25 mg paroxetine per tablet and indicates the package contains 30 tablets. A barcode and manufacturer details for Apotex Inc. in Toronto, Ontario, and Apotex Corp. in Weston, Florida appear on the right side.*

FDA Label Image

Paxilcr37.5mg30counttabletlabel Gsk

Label for PAXIL CR 37.5 mg controlled-release tablets, containing paroxetine hydrochloride. The label displays the strength 37.5 mg and indicates a package of 30 tablets. It includes storage instructions, manufacturer (GlaxoSmithKline, RTP, NC), and distributor details (Apotex Corp., Weston, FL). The label also notes federal law requirements for dispensing with a Medication Guide.*

FDA Label Image

Paxilcr37.5mg30counttabletlabel

Label for PAXIL CR extended-release tablets containing 37.5 mg of paroxetine hydrochloride per tablet. The label includes storage instructions, dosing caution, and safety closure warnings. It lists Apotex Corp as the labeler and indicates a package size of 30 tablets. A barcode and federal law dispensing notice are also visible.*

FDA Label Image

Structure

Chemical structure diagram of the active ingredient in PAXIL CR, depicting molecular bonds and atoms including fluorine and chlorine (HCl). The structure shows a bicyclic ring system with attached functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.